Anika Therapeutics, Inc. Other Noncash Income (Expense)
Anika Therapeutics, Inc. (ANIK) reported Other Noncash Income (Expense) of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2024-03-15
- Anika Therapeutics, Inc. other noncash income (expense) for the quarter ending 2021-12-31 was $5.00K.
- Anika Therapeutics, Inc. other noncash income (expense) for the quarter ending 2020-12-31 was -$7.00K.
- Anika Therapeutics, Inc. other noncash income (expense) for fiscal 2023 was $0.00.
- Anika Therapeutics, Inc. other noncash income (expense) for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Anika Therapeutics, Inc. other noncash income (expense) for fiscal 2021 was $18.00K, a 50.00% increase from fiscal 2020.
- Anika Therapeutics, Inc. other noncash income (expense) for fiscal 2020 was $12.00K, a 52.00% decline from fiscal 2019.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-15 | ||
| 2022-12-31 | $0.00 10-K · filed 2024-03-15 | ||
| 2021-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $18.00K 10-K · filed 2024-03-15 | |
| 2021-09-30 | $13.00K 10-Q · filed 2022-11-09 | ||
| 2020-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $12.00K 10-K · filed 2023-03-16 | |
| 2020-09-30 | $19.00K 10-Q · filed 2021-11-05 | ||
| 2019-12-31 | $25.00K 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |